Topics

Glioblastoma | Etiopathogenesis | Cancer Stem Cells

Home > Publications > Topics > Glioblastoma > Etiopathogenesis > Cancer Stem Cells

Zechel C, Loy M, Wegner C, Dahlke E, Soetje B, Baehr L, Leppert J, Ostermaier JJ, Lueg T, Nielsen J, Elßner J, Willeke V, Marzahl S, Tronnier V, Madany Mamlouk A.
Molecular signature of stem-like glioma cells (SLGCs) from human glioblastoma and gliosarcoma.
PLoS One. 2024 Feb 2;19(2):e0291368. doi: 10.1371/journal.pone.0291368. PMID: 38306361. Laboratory investigation. ˍ

Fei X, Wu J, Tian H, Jiang D, Chen H, Yan K, Wang Y, Zhao Y, Chen H, Xie X, Wang Z, Zhu W, Huang Q.
Glioma stem cells remodel immunotolerant microenvironment in GBM and are associated with therapeutic advancements.
Cancer Biomark. 2024 Aug 4. doi: 10.3233/CBM-230486. PMID: 39240627. Review. ˍ

Gao J, Gu D, Yang K, Zhang J, Lin Q, Yuan W, Zhu X, Dixit D, Gimple RC, You H, Zhang Q, Shi Z, Fan X, Wu Q, Lu C, Cheng Z, Li D, Zhao L, Xue B, Zhu Z, Zhu Z, Yang H, Zhao N, Gao W, Lu Y, Shao J, Cheng C, Hao D, Yang S, Chen Y, Wang X, Kang C, Ji J, Man J, Agnihotri S, Wang Q, Lin F, Qian X, Mack SC, Hu Z, Li C, Taylor MD, Li Y, Zhang N, Rich JN, You Y, Wang X.
Infiltrating plasma cells maintain glioblastoma stem cells through IgG-Tumor binding.
Cancer Cell. 2025 Jan 2:S1535-6108(24)00481-1. doi: 10.1016/j.ccell.2024.12.006. PMID: 39753140. Laboratory investigation˰ ˍ
RELATED ARTICLE
Kirschstein E, Gunderson AJ.
Plasma cell and cancer stem cell crosstalk in glioblastoma.
Cancer Cell. 2025 Jan 2:S1535-6108(24)00482-3. doi: 10.1016/j.ccell.2024.12.007. PMID: 39753137. Comment˰ ˍ

Salmeron-Moreno K, Papisetty K, Kim CD, McCaffery T, Kashlan R, Theodore J, Kim JM, Buclez J, Duggireddy H, Maldonado J, Guerrero-Cázares H, Pradilla G, Garzon-Muvdi T.
Neuro-Oncological Perspectives on Cancer Stem Cell Biology in Glioblastoma: Implications for Resection, Recurrence, Targeted Therapy, and Other CNS Tumors.
Cells. 2026 Feb 27;15(5):413. doi: 10.3390/cells15050413. PMID: 41827847. ˍ